Jane Street
ENZ

Jane Street’s Enzo Biochem, Inc. ENZ Stock Holding History

Jane Street’s Portfolio ENZ Stock Details ENZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-11,560
Closed -$16.1K – 10259
2023
Q4 		$16.1K Buy
+11,560
New +$15.3K ﹤0.01% 8933
2023
Q2 		– Sell
-27,023
Closed -$65.7K – 9746
2023
Q1 		$65.7K Buy
+27,023
New +$40.2K ﹤0.01% 8372
2021
Q3 		– Sell
-77,317
Closed -$245K – 10905
2021
Q2 		$245K Buy
77,317
+62,870
+435% +$198K ﹤0.01% 8504
2021
Q1 		$50K Buy
+14,447
New +$44.9K ﹤0.01% 8840
2020
Q4 		– Sell
-25,915
Closed -$55K – 8239
2020
Q3 		$55K Buy
+25,915
New +$61.6K ﹤0.01% 6898
2019
Q3 		– Sell
-34,444
Closed -$116K – 5895
2019
Q2 		$116K Buy
+34,444
New +$121K ﹤0.01% 4823
2018
Q2 		– Sell
-15,633
Closed -$86K – 5744
2018
Q1 		$86K Buy
+15,633
New +$110K ﹤0.01% 4626
2015
Q3 		– Sell
-39,174
Closed -$119K – 4263
2015
Q2 		$119K Buy
+39,174
New +$110K ﹤0.01% 3398

Other funds holding ENZ

HFA
Harbert Fund Advisors Birmingham, Alabama $3.03M AUM 40.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
RC
RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Jane Street's ENZ Position: Q1 2024 in Review

Jane Street sold out of Enzo Biochem, Inc. (ENZ) in Q1 2024, closing a stake of 11,560 shares — an estimated $16.1K sold.

Jane Street first reported a position in ENZ in Q2 2015 and held it in 8 quarters. The position peaked at $245K in Q2 2021. 41 funds tracked by Wall St. Rank hold ENZ as of Q1 2024.

  • Jane Street reported no remaining Enzo Biochem, Inc. position as of Q1 2024 after selling out during the quarter.
  • Jane Street sold 11,560 Enzo Biochem, Inc. shares in Q1 2024, an estimated $16.1K.
  • Jane Street first reported a position in Enzo Biochem, Inc. in Q2 2015 and held it in 8 quarters.
  • Jane Street's Enzo Biochem, Inc. position peaked at $245K in Q2 2021.
  • 41 funds tracked by Wall St. Rank held Enzo Biochem, Inc. as of Q1 2024.

Based on Jane Street's 13F filing for Q1 2024, filed 16 May 2024.